Tel: +86 (0)571 8102-5280
Email: sales@molcore.com
言語 :
English
中文版
日本語
Search
ホーム
摩库とは
CRO&CDMO
サービス
受託合成
プロセス開発
IP & 品質
試験室·工場のご案内
研究開発センター
協力工場
製品
お問い合わせ
Name インデックス L
ホーム
サイトマップ
Name インデックス L
最近検索されたキーワード
1027513-43-4
,
1036380-87-6
,
81121-20-2
,
105512-85-4
,
776297-29-1
,
868851-35-8
,
87293-37-6
,
1318338-47-4
,
886363-38-8
,
893612-27-6
,
211513-37-0
,
133192-89-9
,
938443-38-0
,
97902-66-4
,
1131614-17-9
,
1161787-69-4
,
1198106-25-0
,
168135-77-1
,
951-97-3
,
512177-83-2
,
784-40-7
,
61370-75-0
,
133-49-3
,
17257-96-4
,
117275-51-1
,
1353965-37-3
,
586357-02-0
,
114973-22-7
,
593-85-1
,
53123-88-9
,
1481-32-9
,
955374-13-7
,
70-07-5
,
894787-30-5
,
929918-85-4
,
1804288-30-9
,
1804418-92-5
,
96624-52-1
,
53917-42-3
,
1894243-23-2
,
1591827-03-0
,
21635-99-4
,
206660-72-2
,
2121513-19-5
,
288251-84-3
,
345637-69-6
,
92157-61-4
,
473839-20-2
,
50690-55-6
,
596817-39-9
,
606144-42-7
,
65655-59-6
,
1083181-28-5
,
634-93-5
,
753444-70-1
,
372524-72-6
,
1932511-73-3
,
1706463-43-5
,
943749-63-1
,
88671-89-0
製品 サイトマップ
Cas インデックス
1
2
3
4
5
6
7
8
9
Name インデックス
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Name インデックス L
SKU
化学名
分子式
MC826199
887769-34-8 | Lercanidipine Impurity D
MC826197
1198299-72-7 | Lenalidomide Impurity A
MC826195
731016-25-4 | Lasofoxifene-N-oxide
MC826194
1346598-28-4 | Lansoprazole Impurity (M+467)
MC826193
1797983-48-2 | Lamotrigine 3-3 Dimer
MC826192
1318777-56-8 | Lacosamide N-Ethylcarbonyl Analog
MC826191
175481-39-7 | Lacosamide EP Impurity E (Lacosamide N-Desacetyl O-Desmethyl Impurity)
MC825884
114799-13-2 | Losartan EP Impurity C
MC825883
165739-83-3 | Loratadine EP Impurity C/ Loratadine Related Compound G
MC825882
133284-74-9 | Loratidine EP Impurity A/ Loratidine Related Compound F
MC825881
1132650-67-9 | Lisinopril EP Impurity F (Lisinopril Cyclohexyl Analog)
MC825880
85955-59-5 | Lisinopril EP Impurity E
MC825879
328385-86-0 | Lisinopril EP Impurity C/ Lisinopri Related Compund A (Lisinopril (S,S,S)-Diketopiperazine)
MC825878
189038-36-6 | Linezolid N-oxide
MC825877
745798-07-6 | Lidocaine Impurity-E
MC825876
1012864-23-1 | Lidocaine Impurity-J(free base)
MC825875
857170-72-0 | Lidocaine EP Impurity F (Lidocaine 2,3-Dimethyl Analog)
MC825874
7729-94-4 | Lidocaine Impurity-D
MC825873
1346603-62-0 | Levofloxacin EP Impurity G/ Levofloxacin Related Compound E (Levofloxacin Desethylene Impurity)
MC825872
1797510-34-9 | Levofloxacin Diamine Impurity
MC825871
178964-53-9 | LevofloxacinEP Impurity E (Levofloxacin Descarboxy Impurity)
MC825870
27244-64-0 | Levodopa EP Impurity A/ Levodopa Related Compound A (2-Hydroxy Levodopa)
MC825868
252186-79-1 | Lamotrigine EP Impurity F/ Lamotrigine Related Compound D
MC825867
252186-78-0 | Lamotrigine EP imp-C /Lamotrigine EP Impurity A
MC825866
94213-23-7 | Lamotrigene Impurity C
MC825865
86921-49-5 | Lacosamide Impurity K
MC825864
175481-38-6 | Lacosamide EP Impurity F (Lacosamide O-Desmethyl Impurity)
MC825863
1318777-54-6 | Lacosamide EP Impurity B (Lacosamide O-Acetyl Impurity)
MC825862
175481-37-5 | Lacosamide EP Impurity A (Lacosamide (S)-Isomer)
C13H18N2O3
MC825861
802620-01-5 | Labetalol EP Impurity B
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
Next
© Copyright 2015-2024 Hangzhou MolCore BioPharmatech Co.,Ltd. All rights reserved.